POSITIVE FEEDBACK ACTION OF OESTRADIOL ON GONADOTROPHIN RELEASE IN 15 DAY OLD FEMALE RATS

1977 ◽  
Vol 86 (2) ◽  
pp. 263-272 ◽  
Author(s):  
J. Kronibus ◽  
W. Wuttke

ABSTRACT Female rats were ovariectomized (ovx), adrenalectomized (adx) or both (adx-ovx) on day 8 after birth. The serum gonadotrophin concentrations on day 15 were higher in ovx and adx-ovx rats than in sham-operated or untreated controls of the same age. Intact animals on day 15 had higher LH and FSH levels compared with adult, dioestrous levels, and a number of LH peaks were observed. After partial separation of oestradiol (LH 20 column chromatography) from other lipid substances which interfere with the radioimmunoassay for oestradiol, levels of oestradiol were undetectable in ovx and in adx-ovx animals on day 15 but concentrations were relatively high in intact or adx rats. To test whether the high gonadotrophin concentrations in 15-day-old intact rats were due to a positive feedback action of oestradiol, silastic tubes containing different amounts of oestradiol were implanted on day 8 at the time of adrenalectomy and ovariectomy. The mean serum LH and FSH concentrations were increased on day 15 in those animals in which silastic tube implantation resulted in physiological oestradiol levels. These elevated gonadotrophin values were due to a number of peak levels. Injection of 600 μg progesterone on day 15, 8 h before decapitation resulted in high FSH levels in all the implanted animals, whereas LH levels were still variable from one animal to another. This situation is very similar to that in intact control rats and it is concluded that the hypothalamo-pituitary axis in 15-day-old female rats reacts to an oestrogenic stimulus followed by a progestational reaction as does the adult "gonadostat". This would account for the premature, pre-ovulatory type of LH peaks.

2020 ◽  
Vol 8 (5) ◽  
pp. 839-856 ◽  
Author(s):  
Kelly L. Klump ◽  
Elaine B. Sinclair ◽  
Britny A. Hildebrandt ◽  
Deborah A. Kashy ◽  
Shannon O’Connor ◽  
...  

Recent research suggests that estrogen is protective against binge eating in adult females and that pubertal estrogen may be critical for these effects. Nonetheless, to date, no study has examined the role of pubertal estrogen in adult binge-eating phenotypes in females, potentially because of difficulties experimentally manipulating estrogen in humans to examine causal effects. We used a novel animal model to examine whether estrogen removal before puberty (via prepubertal ovariectomy, or P-OVX) increased rates of binge-eating-prone (BEP) phenotypes in adulthood in female rats. Seventy-seven P-OVX rats and 79 intact rats were followed from prepuberty into adulthood and phenotyped for BEP status in adulthood. Results showed significantly increased rates (~2–8 times higher) of adult BEP phenotypes in P-OVX compared with intact rats. Findings confirm that estrogen removal substantially increases later risk for binge eating in females, potentially by disrupting typical adolescent brain development.


1975 ◽  
Vol 67 (3) ◽  
pp. 425-430 ◽  
Author(s):  
R. P. DEIS ◽  
NIA ALONSO

SUMMARY The effect of synthetic thyrotrophin releasing factor (TRF) on serum prolactin and LH concentrations was determined by radioimmunoassay in male, cyclic and pseudopregnant female rats. A solution of TRF (0·1, 0·25, 0·5 and 1 μg/rat) was injected i.v. at 17.00 h into rats pretreated with sodium pentobarbitone at 13.00 h. A group of male rats was also treated with TRF at 11.00 h after pretreatment with sodium pentobarbitone at 07.00 h. Fifteen minutes after TRF administration, blood samples were obtained by heart puncture. Doses of 0·25, 0·5 and 1 μg TRF significantly increased the serum prolactin concentration in pro-oestrous rats. The mean serum prolactin level after the injection of 0·5 and 1 μg into oestrous rats and 0·5 μg TRF into dioestrous day 2 rats, was significantly greater than the control values. Injection of TRF on day 1 of dioestrus had no effect. Serum LH concentration was not significantly modified by the various doses of TRF administered. On day 3 of pseudopregnancy a significant increase of serum prolactin values was obtained with 0·5 and 1 μg TRF. On day 7 of pseudopregnancy a dose of 0·5 μg produced the same effect, but on day 10 of pseudopregnancy only 1 μg TRF significantly increased serum prolactin levels when compared with the control rats. In male rats serum prolactin concentration was significantly greater than the control values after TRF treatment either in the morning or the afternoon. The response was similar to that obtained in pro-oestrous rats. The results suggest that the ability of synthetic TRF to stimulate prolactin release exists in both female and male rats and that TRF does not affect LH secretion.


2008 ◽  
Vol 86 (1-2) ◽  
pp. 25-35 ◽  
Author(s):  
Israel Pérez-Torres ◽  
Mohammed El Hafidi ◽  
Oscar Infante ◽  
Guadalupe Baños

We studied the effect of varying levels of sex hormones, induced by ovariectomy and administration of testosterone or estradiol, on aortic reactivity in female rats with metabolic syndrome (MS) induced by a sucrose diet. Vasoreactivity of aortic rings, blood pressure, intra-abdominal fat, serum triglycerides, nitrates and nitrites, and TBARS were evaluated. Intact MS and ovariectomized MS had higher BP than intact control (C) and ovariectomized C, respectively; estradiol administration decreased BP in ovariectomized MS but not in ovariectomized C. Triglycerides and fat were both higher in MS. Triglycerides were not modified by surgery or hormone treatment, but ovariectomy increased fat. When ovariectomy was combined with hormones, however, fat was reduced to the level of intact rats. Ovariectomy decreased, but hormones increased, serum nitrates and nitrites. Vasoconstriction was larger in intact MS and ovariectomized MS + testosterone aortas than in intact C and ovariectomized C + testosterone, respectively. Vasodilation was reduced in intact MS and ovariectomized MS + testosterone compared with intact C, ovariectomized C + testosterone, ovariectomized MS, and ovariectomized MS + estradiol. The results suggest endothelial dysfunction in intact MS and ovariectomized MS + testosterone, but protection by ovariectomy + estradiol in MS due to hormones. Indomethacin reduced all contractions, but the effect was greater in estradiol-treated rats. l-NAME increased contractility, more in the ovariectomized C and MS groups and less in the estradiol-treated groups.


1978 ◽  
Vol 89 (3) ◽  
pp. 590-598 ◽  
Author(s):  
Marie C. Gelato ◽  
J. Meites ◽  
W. Wuttke

ABSTRACT Female Sprague-Dawley derived rats were either sham-operated or adrenalectomized at 20 days of age. Treatment of separate groups of rats with progesterone, corticosterone or prolactin was started at 21 days of age, and was continued until the day of vaginal opening. Similarly treated rats were decapitated at 25, 29 and 33 days of age and at the day of vaginal opening and the sera were collected from each animal and assayed for prolactin, LH and FSH. All rats were decapitated between 4–6 p. m. Adrenalectomy, as previously reported, significantly delayed the day of vaginal opening. Prolactin treatment advanced the day of vaginal opening in intact rats and it restored the day of vaginal opening in adrenalectomized rats to that of intact control rats. Progesterone treatment always delayed the day of vaginal opening in intact rats. It caused an even greater delay in vaginal opening than adrenalectomy alone. Corticosterone treatment, on the other hand, was able to reverse the effect of adrenalectomy but had no effect on vaginal opening in intact rats. In intact rats serum prolactin levels rose steadily until the day of vaginal opening. Adrenalectomized and intact rats treated with progesterone had significantly decreased serum prolactin levels. However, in adrenalectomized corticosterone treated rats serum prolactin levels were significantly increased at all ages measured when compared to the untreated rats. The FSH and LH levels showed no significant changes during any of these experimental procedures. Approximately 50 % of the rats showed LH peaks on the day of vaginal opening as well as an increase in FSH. The data indicate a prolactin-adrenal interaction for the timing of the onset of puberty in immature rats, assuming that the day of vaginal opening in association with increased gonadotrophin levels is an indicator for the occurrence of puberty.


1982 ◽  
Vol 100 (4) ◽  
pp. 492-498 ◽  
Author(s):  
Koji Koike ◽  
Toshihiro Aono ◽  
Hirohisa Tsutsumi ◽  
Akira Miyake ◽  
Keiichi Kurachi

Abstract. The effect of hyperprolactinaemia on the hypothalamo-pituitary axis was assessed by iv injection of 100 μg luteinizing hormone releasing hormone (LRH) in 7 women with prolactinoma before and 3 months after normalization of the Prl level by transsphenoidal surgery. A dose of 20 mg of conjugated oestrogen (Premarin®) was also injected iv into patients with prolactinoma before and 4 months after surgery, and the serum LH levels were determined serially for 120 h after the injection. Surgical treatment caused significant reduction of the mean (± se) serum prolactin (Prl) level from 123.3 ± 7.8 to 19.4 ± 5.6 ng/ml. But the differences in the basal levels of LH (11.3 ± 2.2 to 8.6 ± 1.5 mIU/ml), FSH (8.3 ± 2.4 to 10.6 ± 3.7 mIU/ml) and oestradiol (26.6 ± 8.6 to 37.5 ± 5.5 pg/ml) before and 4 months after surgery were not significant. An exaggerated LH response to LRH in untreated prolactinoma patients was also observed after surgical treatment. After surgical treatment, patients showed LH release with a peak between 48 and 72 h after the injection of Premarin, whereas before treatment they did not show any LH discharge. The mean percent increase in LH between 48 and 72 h was also significantly higher after operation than before operation. These results suggest that the hyperprolactinaemia in prolactinoma patients may cause an impaired positive feedback effect of oestrogen on LH release and that this derangement can be reversed by reduction of the Prl level by adenomectomy.


2002 ◽  
pp. 855-862 ◽  
Author(s):  
V Sibilia ◽  
D Cocchi ◽  
I Villa ◽  
N Lattuada ◽  
A Soglian ◽  
...  

OBJECTIVE: The present study was performed to evaluate the potential influence of the estrogen milieu in modulating the effects of GH/IGF stimulation by a GH-releasing peptide, hexarelin (HEXA), on bone metabolism and mineral density in middle-aged female rats. METHODS: HEXA was administered for 60 days (50 microg/kg s.c. twice a day) to intact and ovariectomized (OVX) 11-month-old female rats and changes in bone parameters were evaluated with respect to those of the same rats under baseline conditions and with those of control rats (intact and OVX) administered isovolumetric amounts of physiological saline. Serum total alkaline phosphatase (ALP) and urinary deoxypyridinoline (Dpd) were measured before and at various times during HEXA treatment. Bone mineral content (BMC) and density of lumbar vertebrae and femoral mid-diaphyses were measured by dual energy X-ray absorptiometry before and after treatment. In all groups, serum IGF-I levels were determined before and during treatment and the GH secretory response to HEXA was assessed at the end of the experiment. RESULTS: In intact rats, HEXA did not modify Dpd urinary excretion, induced a trend toward an increase of serum ALP activity and significantly increased BMC (+6.5%) and bone area (+4.1%) only at lumbar vertebrae. In OVX rats, HEXA did not modify the OVX-induced increase in bone turnover markers (Dpd and ALP) and did not affect the OVX-induced vertebral bone loss, but significantly increased BMC (+7.2%) and bone area (+5.3%) at femoral mid-diaphyses. HEXA significantly increased serum IGF-I levels at day 14, but not at day 60, in both intact and OVX rats, whereas the GH secretory response to HEXA was higher in the former than in the latter. CONCLUSIONS: Overall, the present data demonstrate that chronic HEXA treatment increases BMC and bone area at lumbar vertebrae in intact rats and at femoral diaphyses in OVX rats. The different sensitivity to HEXA of the skeletal districts examined is related to the estrogen milieu and may reflect a complex interplay between estrogens and GH/IGF function.


1983 ◽  
Vol 97 (1) ◽  
pp. 145-153 ◽  
Author(s):  
P. Södersten ◽  
P. Eneroth ◽  
A. Pettersson

Sequential blood samples were obtained at hourly intervals from intact male rats during various phases of the light: darkness cycle. Measurement of the serum concentrations of LH and androgen showed that both hormones were secreted episodically, with a secretory episode defined as an increment and subsequent decrement in the serum hormone level exceeding the analytical intra-assay imprecision. Episodes of androgen secretion varied greatly in amplitude (from 1·04 to 30·90 nmol/l) in individual males, occurred during any phase of the light: darkness cycle and were preceded by one or two episodes of LH secretion. Individual males could show more than one episode of androgen secretion during an 18-h sampling period (mean ± s.e.m. = 1·7 ± 0·7 pulses/10 h). Mean values of serum LH and androgen in groups of animals obscured the episodic pattern of hormone secretion shown by individual animals. Castration reduced serum androgen to non-detectable levels within 2 h and produced a temporary decline in serum LH levels and abolition of the episodic pattern of LH secretion. These effects were prevented by testosterone treatment at the time of castration. There was a gradual increase in serum LH levels and in the amplitude of the LH secretory episodes for 1 week after castration. Treatment of castrated rats with testosterone-filled constant-release implants (10 or 20 mm long) produced high and stable serum androgen levels and episodes of LH secretion of low amplitude 1 week after castration. A constant concentration of serum androgen comparable to the mean level of intact rats, produced by implantation of 5 mm long testosterone implants 3 weeks earlier, resulted in a pattern of episodic LH secretion which was similar to that of intact rats. Subcutaneous injection of various doses of testosterone (5, 15 or 45 μg) in castrated rats produced a dose-dependent increase in serum androgen levels within 30 min of injection and thereafter the levels declined. Injection of 15 μg testosterone produced a pulse-like increase in serum androgen concentrations with an amplitude within the range of that observed in intact rats. Injection of this amount of testosterone in castrated rats in which serum LH levels had been suppressed by prior implantation of 20 mm long testosterone implants produced no change in serum LH levels. It is suggested that androgen primarily modifies the amplitude of the LH secretory episodes and that episodic fluctuations in serum androgen levels have no immediate effect on the pattern of LH secretion. Constant serum androgen levels comparable to the mean level of intact rats are sufficient for maintenance of the normal episodic pattern of LH secretion.


1982 ◽  
Vol 100 (4) ◽  
pp. 499-503 ◽  
Author(s):  
A. A. J. Jenner ◽  
J. de Koning ◽  
G. P. van Rees

Abstract. Anterior hemi-pituitary glands from intact female and ovariectomized (OVX) rats were incubated with or without a maximally effective dose of LRH. During an 8 h incubation, LRH-stimulated release of FSH by pituitary glands from intact rats was biphasic: an initial slow rate of release and, from 2 to 8 h, an enhanced rate of release. Basal release was low up to 4 h, after which a marked increase of the rate of release was measured: from 6 to 8 h there was no difference between the rates of basal and LRH-stimulated release. Basal and LRH-stimulated release of FSH by pituitary glands from OVX rats were high and approximately constant during an 8 h incubation. Both basal and LRH-stimulated release by glands from intact as well as OVX rats were protein synthesis dependent. During the incubations an LRH-independent synthesis of FSH was measured. The results suggest that this synthesis is involved, either directly or indirectly, in increasing the rate of basal release of FSH after 4 h. A comparison of release and synthesis of FSH with those of LH reveals characteristic differences.


1985 ◽  
Vol 108 (4) ◽  
pp. 440-444 ◽  
Author(s):  
Yasuhito Nagahara ◽  
Akira Miyake ◽  
Keiichi Tasaka ◽  
Yasuhiro Kawamura ◽  
Toshihiro Aono ◽  
...  

Abstract. For determination of the site of action of oestrogen (E) during the negative and positive feedback phases of gonadotrophin secretions, studies were made on the pituitary response to a small amount of LRH and the pulsatility of gonadotrophins after E administration in normal cycling women in the mid-follicular phase. The pituitary responses to an iv bolus of 2.5 μg of synthetic LRH were evaluated by measuring serum LH and FSH 2 h before and 8 h after administration of 20 mg of conjugated E (Premarin). In the next cycle, the pituitary responses to a same dose of LRH were also observed 2 h before and 56 h after E injection. The mean levels of serum LH and FSH and the peak responses to LRH were significantly (P < 0.05) decreased 8 h after E injection, but were significantly (P < 0.05) increased 56 h after E administration. In the third cycle, the pulsatility of gonadotrophins was evaluated by measuring serum LH and FSH every 15 min for 180 min before and 8 h and 56 h after E injection. The pulse frequencies of gonadotrophins were not significantly different before and 8 h and 56 h after E injection. The amplitudes of pulses 56 h after Premarin injection were significantly higher than those before the injection. These findings suggest that the negative and positive feedback effects of E on gonadotrophin secretion may be caused, in part, by its direct action on the pituitary response to LRH.


1977 ◽  
Vol 85 (2) ◽  
pp. 225-234 ◽  
Author(s):  
R. J. Orts ◽  
K. M. Kocan ◽  
R. P. Johnson

ABSTRACT Bovine pineal glands were extracted with acetic acid and partially purified on Sephadex G-25. Three fractions, F3, F4 and F5, were each administered to cycling female rats for 4, 2 or 1 day prior to ovulation to determine their effects on fertility, ovulation and the pro-oestrous surge of luteinizing hormone (LH). The incidence of pregnancy and the mean number of foetuses were reduced in animals after treatment with F3 or F4 but not in those treated with F5. Each of the F3 and F4 fractions significantly reduced the mean number of ova shed and the pre-ovulatory concentration of serum LH. The F5 fraction caused a moderate reduction of the pro-oestrous rise of serum LH but had no significant effect on ovulation. The data suggest that fertility in rats can be reduced by more than one substance of low molecular weight present in bovine pineal extracts through a modifying effect on LH secretion and subsequent ovulation.


Sign in / Sign up

Export Citation Format

Share Document